Follow us
Indian Institue of Technology Delhi and National Institue of Immunology signed a pact to create a Ph.D programme to help create better and new technologies for diseases like cancer and tuberculosis.
An MoU has been signed between Indian Institute of Technology (IIT) Delhi and National Institute of Immunology (NII) Delhi. The MoU will come with a joint PhD Programme to develop new technologies that will help in treating diseases like tuberculosis, cancer, etc.
The director of IIT Delhi, V Ramgopal Rao said that the partnership will bring biotechnologists and engineers together to develop technologies that will be applicable in the field medicine and in the treatment of the diseases like cancer. He also states that the faculty members for the programme will be funded by them for the first two years after which they can seek out external funding.
Rao specifies that the researchers will work towards studying and creating projects on topics like cell biology, tuberculosis, cancer, etc. They will also work on understanding the mechanical properties of the cell that are affected by the disease as well as developing technologies that will help the treatment for such disease be smooth.
Also Read:IIT Delhi and NII Join Hands for Various Research Courses
The Partnership will help the faculty members of IIT Delhi and the scientists of NII Delhi with funding, says Rao, so as to help them create 20 interdisciplinary research projects between the two institutions.
Also Read:IIT Roorkee and ISRO Come Together to Form a Space Technology Cell
This is one of the many collaboration that the Indian Institute of Technology has made between other institutions. One of the other collaborations that IIT Delhi has made is with AIIMS (All India Institute of Medical Sciences), where they will partner with each other to build a total of 30 research projects in medical diagnosis.
